From the Stritch School of Medicine, Loyola University, Chicago, Illinois.
Obstet Gynecol. 2011 Nov;118(5):1108-1110. doi: 10.1097/AOG.0b013e31823402f6.
To describe the frequency, patterns, and associations of Obstetrics & Gynecology author conflict of interest disclosures over a 2-year period.
All original research articles published in Obstetrics & Gynecology between July 2008 and June 2010 were individually reviewed to record conflict of interest disclosures. For each article, we assessed the number of authors, the proportion of authors with disclosures, and the assigned level of evidence. For each author, we assessed the number of disclosures. For individuals who participated as authors on more than a single article during this time period and reported disclosure at least once, we also assessed the consistency of the individual's conflict of interest disclosures.
Nineteen percent of articles contained at least one disclosure with a range of one to 73 disclosure per article (median 3). Nearly one third (31%) of articles with disclosures were randomized clinical trials. Articles contributing level I evidence were somewhat more likely to have disclosures (34% compared with 16% and 17% for those reporting levels II and III evidence, P=.004). The median study duration was shorter for articles with disclosures (36 compared with 54 months, P=.003). There were 2,017 unique authors with a range one to 25 per article (median 5). Three hundred twenty-five (16%) were "repeat" authors. Disclosure inconsistencies were noted in 12% of these repeat authors (40/325).
Conflict of interest is disclosed in approximately 20% of original research articles, is more common in level I evidence papers, and appears inconsistent for 12% of repeat authors, suggesting an opportunity to improve disclosure practices.
描述妇产科作者利益冲突披露在两年期间的频率、模式和关联。
单独审查 2008 年 7 月至 2010 年 6 月期间在《妇产科》杂志上发表的所有原始研究文章,以记录利益冲突披露情况。对于每篇文章,我们评估了作者人数、有披露的作者比例以及指定的证据水平。对于每位作者,我们评估了披露的次数。对于在这段时间内作为作者参与超过一篇文章且至少报告过一次披露的个人,我们还评估了个人利益冲突披露的一致性。
19%的文章至少有一次披露,每篇文章的披露次数从 1 次到 73 次不等(中位数为 3 次)。近三分之一(31%)有披露的文章为随机临床试验。具有披露的文章更有可能提供一级证据(34%比报道二级和三级证据的文章分别为 16%和 17%,P=0.004)。有披露的文章的中位研究持续时间较短(36 个月比 54 个月,P=0.003)。有 2017 位具有单一至 25 次文章(中位数为 5 次)的独特作者。其中 325 位(16%)为“重复”作者。在这些重复作者中,有 12%(40/325)的披露不一致。
利益冲突在大约 20%的原始研究文章中被披露,在一级证据文章中更为常见,在 12%的重复作者中显示出不一致性,表明有机会改进披露做法。